2. Academic Validation
  3. Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90

Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90

  • Cancers (Basel). 2016 Aug 24;8(9):77. doi: 10.3390/cancers8090077.
Alex Henke 1,  Omar E Franco 2,  Grant D Stewart 3,  Antony C P Riddick 4,  Elad Katz 5,  Simon W Hayward 6,  Axel A Thomson 7
Affiliations

Affiliations

  • 1 Medical Research Council, Centre for Reproductive Health, The Queens's Medical Research Institute, Edinburgh EH16 4TJ, UK. dr.a.henke@gmail.com.
  • 2 Department of Urologic Surgery and Cancer Biology, Vanderbilt University, Nashville, TN 37232-2765, USA. ofrancocoronel@northshore.org.
  • 3 Edinburgh Urological Cancer Group, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK. grant.stewart@ed.ac.uk.
  • 4 Edinburgh Urological Cancer Group, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK. ariddick@doctors.org.uk.
  • 5 Division of Pathology, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK. e.katz@dundee.ac.uk.
  • 6 Department of Urologic Surgery and Cancer Biology, Vanderbilt University, Nashville, TN 37232-2765, USA. SHayward@northshore.org.
  • 7 Division of Urology, Department of Surgery, Cancer Research Program, McGill University Health Centre Research Institute, 1001 Decarie Blvd, Montreal, QC H4A 3J1, Canada. axel.thomson@mcgill.ca.
PMID: 27563925 DOI: 10.3390/cancers8090077
Abstract

Background: Prostate cancer-associated fibroblasts (CAF) can stimulate malignant progression and invasion of prostatic tumour cells via several mechanisms including those active in extracellular matrix;

Methods: We isolated CAF from prostate Cancer patients of Gleason Score 6-10 and confirmed their cancer-promoting activity using an in vivo tumour reconstitution assay comprised of CAF and BPH1 cells. We tested the effects of heat shock protein 90 (HSP90) inhibitors upon reconstituted tumour growth in vivo. Additionally, CAF contractility was measured in a 3D collagen contraction assay and migration was measured by scratch assay;

Results: HSP90 inhibitors dipalmitoyl-radicicol and 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) reduced tumour size and proliferation in CAF/BPH1 reconstituted tumours in vivo. We observed that the most contractile CAF were derived from patients with lower Gleason Score and of younger age compared with the least contractile CAF. HSP90 inhibitors radicicol and 17-DMAG inhibited contractility and reduced the migration of CAF in scratch assays. Intracellular levels of HSP70 and HSP90 were upregulated upon treatment with HSP90 inhibitors. Inhibition of HSP90 also led to a specific increase in transforming growth factor beta 2 (TGFβ2) levels in CAF;

Conclusions: We suggest that HSP90 inhibitors act not only upon tumour cells, but also on CAF in the tumour microenvironment.

Keywords

cancer associated fibroblast; contractility; heat shock protein; prostate cancer.

Figures
Products